NetScientific (NSCI)

Sector:

Financials

65.70p
   
  • Change Today:
    -3.30p
  • 52 Week High: 81.00p
  • 52 Week Low: 49.00p
  • Currency: UK Pounds
  • Shares Issued: 23.95m
  • Volume: 2,236
  • Market Cap: £15.73m
  • RiskGrade: 410

Deal with Barclays    Trade now with Barclays Stockbrokers

NetScientific's ProAxsis appoints North American distributor

By Josh White

Date: Thursday 19 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
The AIM-traded firm said DiaPharma, based in Ohio, specialised in the commercialisation of products within the research and diagnostic fields in the United States and Canada, and had done so since it was founded in 1997.

It said the partnership agreement provided DiaPharma with exclusive access to ProAxsis' activity-based immunoassay kits for the quantification of the active forms of neutrophil elastase, proteinase 3 and cathepsin G.

"We're delighted to have reached this agreement with DiaPharma," said ProAxsis chief executive officer Dr David Ribeiro.

"Finding a suitable commercial partner for our portfolio in North America was a key short-term objective for the company and we are very excited about partnering with a company that has such experience in the commercialisation of research-focused products in this region of substantial commercialisation potential."

John Clarkson, chairman of NetScientific, said that following the acquisition of all outside shareholdings, the appointment was "another significant step" in the continued planned business growth of ProAxsis and accelerating its progress into international markets.

"ProAxsis has made strong progress this year and this latest announcement illustrates the increased potential for its respiratory diagnostics offering in a post Covid-19 world.

"This also reinforces NetScientific's strategy of expanding cross-Atlantic bridges for our portfolio companies."

At 1520 GMT, shares in NetScientific were flat at 48p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

NetScientific Market Data

Currency UK Pounds
Share Price 65.70p
Change Today -3.30p
% Change -4.79 %
52 Week High 81.00p
52 Week Low 49.00p
Volume 2,236
Shares Issued 23.95m
Market Cap £15.73m
RiskGrade 410

NetScientific Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.67% above the market average37.67% above the market average37.67% above the market average37.67% above the market average37.67% above the market average
21.90% above the sector average21.90% above the sector average21.90% above the sector average21.90% above the sector average21.90% above the sector average
Price Trend
65.49% above the market average65.49% above the market average65.49% above the market average65.49% above the market average65.49% above the market average
48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average48.28% above the sector average
Income Not Available
Growth
51.63% above the market average51.63% above the market average51.63% above the market average51.63% above the market average51.63% above the market average
57.01% above the sector average57.01% above the sector average57.01% above the sector average57.01% above the sector average57.01% above the sector average

NetScientific Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
09:03 2,000 @ 69.20p
09:00 2 @ 65.00p
09:00 2 @ 65.00p
08:46 234 @ 68.22p

NetScientific Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page